Global Biobanking Market 2022-2028

November 2022 | 75 pages | ID: GDE00FA50222EN
Gen Consulting Company

Abstracts

Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. The global biobanking market size is projected to grow by USD 18.0 billion from 2022 to 2028, registering a CAGR of 4.5 percent, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biobanking market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the biobanking industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the sample type, type, biobank format, ownership, application, and region. The global market for biobanking can be segmented by sample type: biofluids, DNA/RNA, stem cells, tissues, others. The biofluids segment captured the largest share of the market in 2021. Biobanking market is further segmented by type: partnership, standalone. The standalone segment held the largest share of the global biobanking market in 2021 and is anticipated to hold its share during the forecast period. Based on biobank format, the biobanking market is segmented into: diseased-oriented biobanks, population-based biobanks. In 2021, the diseased-oriented biobanks segment made up the largest share of revenue generated by the biobanking market. On the basis of ownership, the biobanking market also can be divided into: national & regional agencies, universities, non-profit organization, private organization. Among these, the national & regional agencies segment was accounted for the highest revenue generator in 2021. Biobanking market by application is categorized into: research, therapeutics. The biobanking market by region can be segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By sample type:

• biofluids
• DNA/RNA
• stem cells
• tissues
• others

By type:

• partnership
• standalone

By biobank format:

• diseased-oriented biobanks
• population-based biobanks

By ownership:

• national & regional agencies
• universities
• non-profit organization
• private organization

By application:

• research
• therapeutics

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The global biobanking market report offers detailed information on several market vendors, including All of Us, Auria Biobank, Biobank Graz, BioBank Japan (BBJ), Biobank VAST, China Kadoorie Biobank (CKB), China National GeneBank DataBase (CNGB), Danish National Biobank, deCODE genetics, Inc., EuroBioBank, Kaiser Permanente Research Bank, National Liver Disease Biobank, NIGMS Human Genetic Cell Repository, The Cancer Human Biobank (caHUB), THL Biobank/Finnish Institute for Health and Welfare (THL), UK Biobank Limited, Uppsala Biobank, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global biobanking market.
• To classify and forecast the global biobanking market based on sample type, type, biobank format, ownership, application, region.
• To identify drivers and challenges for the global biobanking market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biobanking market.
• To identify and analyze the profile of leading players operating in the global biobanking market.

Why Choose This Report

• Gain a reliable outlook of the global biobanking market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY SAMPLE TYPE

Biofluids
DNA/RNA
Stem cells
Tissues
Others

PART 6. MARKET BREAKDOWN BY TYPE

Partnership
Standalone

PART 7. MARKET BREAKDOWN BY BIOBANK FORMAT

Diseased-oriented biobanks
Population-based biobanks

PART 8. MARKET BREAKDOWN BY OWNERSHIP

National & regional agencies
Universities
Non-profit organization
Private organization

PART 9. MARKET BREAKDOWN BY APPLICATION

Research
Therapeutics

PART 10. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 11. KEY COMPANIES

All of Us
Auria Biobank
Biobank Graz
BioBank Japan (BBJ)
Biobank VAST
China Kadoorie Biobank (CKB)
China National GeneBank DataBase (CNGB)
Danish National Biobank
deCODE genetics, Inc.
EuroBioBank
Kaiser Permanente Research Bank
National Liver Disease Biobank
NIGMS Human Genetic Cell Repository
The Cancer Human Biobank (caHUB)
THL Biobank/Finnish Institute for Health and Welfare (THL)
UK Biobank Limited
Uppsala Biobank
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER